115 related articles for article (PubMed ID: 24440371)
21. Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains.
Fawley WN; Underwood S; Freeman J; Baines SD; Saxton K; Stephenson K; Owens RC; Wilcox MH
Infect Control Hosp Epidemiol; 2007 Aug; 28(8):920-5. PubMed ID: 17620238
[TBL] [Abstract][Full Text] [Related]
22. Evolutionary clade affects resistance of Clostridium difficile spores to Cold Atmospheric Plasma.
Connor M; Flynn PB; Fairley DJ; Marks N; Manesiotis P; Graham WG; Gilmore BF; McGrath JW
Sci Rep; 2017 Feb; 7():41814. PubMed ID: 28155914
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of "sporicidal" wipes against Clostridium difficile.
Siani H; Cooper C; Maillard JY
Am J Infect Control; 2011 Apr; 39(3):212-8. PubMed ID: 21458683
[TBL] [Abstract][Full Text] [Related]
24. Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model.
Baines SD; Freeman J; Wilcox MH
J Antimicrob Chemother; 2005 Jun; 55(6):974-82. PubMed ID: 15860551
[TBL] [Abstract][Full Text] [Related]
25. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
[TBL] [Abstract][Full Text] [Related]
26. Physical and chemical factors influencing the germination of Clostridium difficile spores.
Wheeldon LJ; Worthington T; Hilton AC; Elliott TS; Lambert PA
J Appl Microbiol; 2008 Dec; 105(6):2223-30. PubMed ID: 19120667
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and protective efficacy of Clostridium difficile spore proteins.
Ghose C; Eugenis I; Edwards AN; Sun X; McBride SM; Ho DD
Anaerobe; 2016 Feb; 37():85-95. PubMed ID: 26688279
[TBL] [Abstract][Full Text] [Related]
28. Sporicides for Clostridium difficile—do they do what it says on the tin?
Fraise AP;
J Hosp Infect; 2015 Jan; 89(1):1. PubMed ID: 25443502
[No Abstract] [Full Text] [Related]
29. Development of a sporicidal test method for Clostridium difficile.
Fraise AP; Wilkinson MA; Bradley CR; Paton S; Walker J; Maillard JY; Wesgate RL; Hoffman P; Coia J; Woodall C; Fry C; Wilcox M
J Hosp Infect; 2015 Jan; 89(1):2-15. PubMed ID: 25477061
[TBL] [Abstract][Full Text] [Related]
30. Unlocking the Sporicidal Potential of Ethanol: Induced Sporicidal Activity of Ethanol against Clostridium difficile and Bacillus Spores under Altered Physical and Chemical Conditions.
Nerandzic MM; Sunkesula VC; C TS; Setlow P; Donskey CJ
PLoS One; 2015; 10(7):e0132805. PubMed ID: 26177038
[TBL] [Abstract][Full Text] [Related]
31. Induced sporicidal activity of chlorhexidine against Clostridium difficile spores under altered physical and chemical conditions.
Nerandzic MM; Donskey CJ
PLoS One; 2015; 10(4):e0123809. PubMed ID: 25861057
[TBL] [Abstract][Full Text] [Related]
32. Co-amoxiclav induces proliferation and cytotoxin production of Clostridium difficile ribotype 027 in a human gut model.
Chilton CH; Freeman J; Crowther GS; Todhunter SL; Nicholson S; Wilcox MH
J Antimicrob Chemother; 2012 Apr; 67(4):951-4. PubMed ID: 22279183
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial efficacy of copper surfaces against spores and vegetative cells of Clostridium difficile: the germination theory.
Wheeldon LJ; Worthington T; Lambert PA; Hilton AC; Lowden CJ; Elliott TS
J Antimicrob Chemother; 2008 Sep; 62(3):522-5. PubMed ID: 18544601
[TBL] [Abstract][Full Text] [Related]
34. The effectiveness of sodium dichloroisocyanurate treatments against Clostridium difficile spores contaminating stainless steel.
Ungurs M; Wand M; Vassey M; O'Brien S; Dixon D; Walker J; Sutton JM
Am J Infect Control; 2011 Apr; 39(3):199-205. PubMed ID: 21288600
[TBL] [Abstract][Full Text] [Related]
35. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
Stevens V; Dumyati G; Brown J; Wijngaarden E
Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
[TBL] [Abstract][Full Text] [Related]
36. Molecular basis of early stages of Clostridium difficile infection: germination and colonization.
Sarker MR; Paredes-Sabja D
Future Microbiol; 2012 Aug; 7(8):933-43. PubMed ID: 22913353
[TBL] [Abstract][Full Text] [Related]
37. Effect of hospital disinfectants on spores of clinical Brazilian Clostridium difficile strains.
Ferreira TG; Barbosa TF; Teixeira FL; Ferreira Ede O; Duarte RS; Domingues RM; de Paula GR
Anaerobe; 2013 Aug; 22():121-2. PubMed ID: 23644034
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection.
Crowther GS; Baines SD; Todhunter SL; Freeman J; Chilton CH; Wilcox MH
J Antimicrob Chemother; 2013 Jan; 68(1):168-76. PubMed ID: 22966180
[TBL] [Abstract][Full Text] [Related]
39. Transformation of ethyl alcohol to ethyl nitrite in acidified saliva: possibility of its occurrence in the stomach.
Takahama U; Tanaka M; Hirota S
Arch Biochem Biophys; 2008 Jul; 475(2):135-9. PubMed ID: 18471427
[TBL] [Abstract][Full Text] [Related]
40. Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model.
Baines SD; Saxton K; Freeman J; Wilcox MH
J Antimicrob Chemother; 2006 Nov; 58(5):1062-5. PubMed ID: 17030519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
